NVAX: second_quarter 2026 lobbying report

{"url":"https://lda.gov/api/v1/filings/0eaf34ad-b2e1-4ebc-b1cc-d2190b084800/","filing_uuid":"0eaf34ad-b2e1-4ebc-b1cc-d2190b084800","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/0eaf34ad-b2e1-4ebc-b1cc-d2190b084800/print/","filing_document_content_type":"text/html","income":null,"expenses":"130000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Kelly Cappio","dt_posted":"2026-07-17T11:30:07-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"21 Firstfield Rd.","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"Gaithersburg","registrant_state":"MD","registrant_zip":"20878","registrant":{"id":401104157,"url":"https://lda.gov/api/v1/registrants/401104157/","house_registrant_id":null,"name":"NOVAVAX, INC","description":"clinical-stage vaccine company","address_1":"21 Firstfield Rd.","address_2":null,"address_3":null,"address_4":null,"city":"Gaithersburg","state":"MD","state_display":"Maryland","zip":"20878","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KELLY CAPPIO","contact_telephone":"+1 240-268-2000","dt_updated":"2026-07-17T11:20:20.440611-04:00"},"client":{"id":200870,"url":"https://lda.gov/api/v1/clients/200870/","client_id":12,"name":"NOVAVAX, INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":"MD","ppb_state_display":"Maryland","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-08-17"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to federal vaccine programs and vaccine regulatory frameworks","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64675,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CAPPIO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}